stars 1 stars 2 stars 3

AccuGenomics is a developer of a unique spike-in control technology that dramatically improves the accuracy and performance of clinical sequencing tests for low abundance biomarkers such as circulating tumor DNA (ctDNA) and low titer infectious pathogens such as SARS-CoV-2. Standardized Nucleic Acid Quantification for Sequencing (SNAQ™-SEQ) is an innovative QC method that uses mixtures of synthetic DNA or RNA internal standards (MIS™) spiked into each sample prior to NGS library prep. Being mixed with the sample and biochemically identical to the regions of interest, these standards undergo the same processing, handling and reaction conditions as the sample does, to provide the ideal run control approach for NGS-based assays. SNAQ-SEQ spike-in controls provide much higher confidence in the results of sequencing tests, eliminate false positives and dramatically reduce false negatives resulting in better overall accuracy as compared to using external (or no) controls alone.

View Top Employees from AccuGenomics

AccuGenomics Questions

The AccuGenomics annual revenue was $6 million in 2024.

3 people are employed at AccuGenomics.

AccuGenomics is based in Wilmington, North Carolina.

The NAICS codes for AccuGenomics are [541, 54171, 5417, 54, 541714].

The SIC codes for AccuGenomics are [87, 873].

Top AccuGenomics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users